ORGO

Organogenesis Holdings Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & GenericUS

USD2.43

+0.01 (+0.41%)

Rating:C+

Company Profile

CEO

Gary S. Gillheeney

IPO Date

2017-01-05

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

Market Metrics

Open

$2.39

Prev. Close

$2.42

Day Low

$2.31

Day High

$2.44

52W Low

$2.04

52W High

$7.08

Market Cap

$0.31B

Volume

0.57M

News SentimentNeutral

Articles

Avg Positive

15.0%

Avg Negative

6.9%

Avg Neutral

78.0%

News Feed

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2021 Financial Results on August 9, 2021

GlobeNewsWire·7/2/2021·↑ positive

Why Organogenesis Holdings Blasted 7.7% Higher Today

The Motley Fool·5/27/2021·↑ positive

Organogenesis Holdings Inc. (ORGO) CEO Gary Gillheeney on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/11/2021·↓ negative